ALEC
ALEC
NASDAQ · Biotechnology

Alector Inc

$1.92
-0.03 (-1.54%)
As of Sep 28, 10:15 PM ET ·
Financial Highlights (FY 2026)
Revenue
21.74M
Net Income
-147,659,235
Gross Margin
—
Profit Margin
-679.2%
Rev Growth
-46.0%
D/E Ratio
0.32
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin — — 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 21.74M 40.25M 87.33M 87.17M
Gross Profit — — 56.35M 56.25M
Operating Income -161,148,916 -268,531,798 7.53M 7.07M
Net Income -147,659,235 -246,053,159 8.20M 6.12M
Gross Margin — — 64.5% 64.5%
Operating Margin -741.3% -667.2% 8.6% 8.1%
Profit Margin -679.2% -645.2% 9.4% 7.0%
Rev Growth -46.0% -46.0% +6.5% -4.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.81M 25.81M 37.32M 37.66M
Total Equity 81.66M 81.66M 74.11M 65.78M
D/E Ratio 0.32 0.32 0.50 0.57
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -155,256,604 -273,086,046 10.19M 12.10M
Free Cash Flow — — 6.96M 5.08M